600196 复星医药
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资27,291,3163.49%26,371,62524,691,50123,919,39923,144,771
投资性房地产0--0000
固定资产18,409,5472.40%17,977,27117,385,19515,129,37110,267,859
在建工程2,949,004-3.48%3,055,4313,435,4514,938,2814,896,697
无形资产14,098,1060.71%13,999,15414,468,39313,482,01612,471,057
商誉10,796,766-0.12%10,809,75710,905,08310,851,99910,337,053
其他非流动资产15,456,96510.25%14,020,05912,083,88411,355,96910,767,292
89,001,7043.21%86,233,29882,969,50779,677,03671,884,729

流动资产
货币资金13,066,486-0.29%13,104,22913,523,93313,693,59116,241,313
应收账款9,467,9511.10%9,364,5227,952,0737,643,7367,588,099
存货6,031,742-3.53%6,252,4727,258,6497,537,7686,882,432
其他流动资产5,398,5055.86%5,099,4485,756,4064,917,4744,567,333
33,964,6840.43%33,820,67134,491,06133,792,56935,279,178

流动负债
短期借款16,355,6755.32%15,529,94018,711,31514,728,45411,931,537
应付票据376,50930.75%287,969619,015652,252857,879
应付帐款4,618,072-4.90%4,856,0455,378,3705,507,3665,426,162
其他流动负债15,230,458-3.30%15,750,36212,743,96912,869,51115,082,491
36,580,7140.43%36,424,31637,452,66933,757,58433,298,069
流动资产净值(2,616,030)0.48%(2,603,645)(2,961,609)34,9851,981,109
资产总额减流动负债86,385,6743.30%83,629,65380,007,89879,712,02173,865,838

非流动负债
长期借款10,076,871-2.75%10,361,99110,203,50013,504,92311,600,437
应付债券2,500,00066.67%1,500,000240,0000499,431
其他非流动负债10,139,4542.14%9,927,3129,630,6699,590,8387,657,060
22,716,3254.25%21,789,30320,074,16923,095,76119,756,928

总权益
    实收股本2,670,4290.00%2,670,4292,671,3262,672,3992,672,157
    储备项目46,476,3150.88%46,071,07844,589,78043,012,36341,910,301
股东权益49,146,7450.83%48,741,50747,261,10745,684,76244,582,458
非控股权益14,522,60410.87%13,098,84312,672,62210,931,4999,526,452